To Test or Not To Test
-
Upload
carrington -
Category
Documents
-
view
24 -
download
0
description
Transcript of To Test or Not To Test
![Page 1: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/1.jpg)
To Test or Not To Test
John Jordan, MD, MPHMedical Director
DSHS HSR 6/5 South
![Page 2: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/2.jpg)
DISCLOSURE STATEMENTConflict of Interest
I have no real or perceived vested interests that relate to this presentation nor do I have any relationships with pharmaceutical companies, biomedical device manufacturers, and/or other corporations whose products or services are related to pertinent therapeutic areas.
![Page 3: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/3.jpg)
DISCLOSURE STATEMENTCommercial support
There is no commercial company support for this CNE activity.
Non-Endorsement of Products The Center for Health Training approval status refers only to continuing nursing education activities and does not imply that there is a real or implied endorsement of any product, service, or company referred to in this activity nor of any company subsidizing costs related to the activity.
Off-Label Product UseThis CNE activity does not include any unannounced information about off-label use of a product for a purpose other than that for which it was approved by the Food and Drug Administration (FDA).
![Page 4: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/4.jpg)
LEARNING OBJECTIVESAt the conclusion of this training,
participants will be able to…
• Describe the impact of HIV in Jefferson Co• Discuss the 2006 CDC Revised
Recommendations for HIV Testing• Recognize the benefits of implementing
routine opt-out testing• Explain the ethical issues related to
routine HIV testing in medical settings
![Page 5: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/5.jpg)
Since the first cases were diagnosed 30 years ago -
•Over 575,000 Americans have lost their lives to AIDS
•More than 56,000 people in the US become infected with HIV each year
•There are more than 1.1 million Americans living with HIV
•Almost half of all Americans know someone living with HIV
![Page 6: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/6.jpg)
![Page 7: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/7.jpg)
Texas HIV/AIDS Trends - 2009
• 66,126 persons were living with HIV/AIDS in Texas through 12-31-09.
• 4,355 new HIV cases were
reported in Texas in 2009. Gender
78% Male (3,379)22% Female (976)
Race: 44% African American
(1,893) 30% Hispanic (1,322) 24% White (1,066) 1% Other (47) 1 % Unknown (27)
1%1%
24%30%
44%
AfricanAmerican
White
Hispanic
Other
Unk/Other
78%
22%
Male
Female
![Page 8: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/8.jpg)
Newly-diagnosed HIV Case Rates by Race/Ethnicity: Texas, 1999-2009
0
10
20
30
40
50
60
70
80
90
100
99 00 01 02 03 04 05 06 07 08 09Year of Diagnosis
Cas
es p
er 1
00,0
00
Hispanic Black White
![Page 9: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/9.jpg)
Percent of Total HIV Diagnoses that were Late Diagnoses* by Race/Ethnicity and Sex, Texas
2009
23%
29%
20%22%
18%16%
0%
10%
20%
30%
40%
Black White Hispanic
Per
cent
(%
)
Male Female
*AIDS diagnosis occurred within 1 month of HIV diagnosis
![Page 10: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/10.jpg)
Jefferson County HIV/AIDS Trends - 2009
• 799 persons living with HIV/AIDS in Jefferson County through 12-31-09.
• 71 new HIV cases were
reported in Jefferson County in 2009.Gender
58% Male (41) 42% Female (30)
Race: 75% African American
(53) 17% White (12)7% Hispanic (5)1% Unknown (1)
5, 7%
1, 1%
12, 17%
53, 75%
AfricanAmerican
White
Hispanic
Unk/Other
30, 42% 41,
58%
Male
Female
![Page 11: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/11.jpg)
Jefferson CountyNew HIV Cases by Race & Sex
2009 – (n=71)
0
5
10
15
20
25
30
35
Af Am White Hispanic
male
female
![Page 12: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/12.jpg)
12
Jefferson County Newly Reported HIV Cases 2002 – 2009
57 57 58
43
58
6871
55
0
10
20
30
40
50
60
70
80
2002 2003 2004 2005 2006 2007 2008 2009
![Page 13: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/13.jpg)
Jefferson County – New HIV Cases by City of Residence – 2009 (n=71)
• Beaumont53 new HIV cases in 2009
31 Males22 Females
• Port Arthur 15 new HIV cases in 2009
8 Males 7 Females
• Other Jefferson Co Cases3 new HIV cases in 2009
2 Males 1 Female
Beaumont
22, 42%
31, 58%
Male
Female
Port Arthur
7, 47%8, 53%
Male
Female
![Page 14: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/14.jpg)
The Problem
• Every 9 ½ minutes someone in the U.S. is infected with HIV.
• More than 20% of those living with HIV do not know it.
• Late diagnosis contributes to:– Poor outcomes, decreased productivity,
and early death;– Increased health care costs and;– More transmission of HIV
![Page 15: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/15.jpg)
Effect of Awareness on Transmission
~25% Unaware of
Infection
~75% Aware of Infection
People with HIV/AIDS: 1,039,000-1,185,000
New Sexual Infections Each Year: ~32,000
Accounting for:~54% of
New Infections
~46% of New
Infections
Marks, et alAIDS 2006;20:1447-50
![Page 16: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/16.jpg)
The Facts• Persons who do not know they are
infected with HIV may be responsible for more than half of new transmissions
• Most of those unaware of their infection visit a health care facility but are not tested for HIV
![Page 17: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/17.jpg)
Source of HIV Tests & Positive Tests
HIV tests* HIV+ tests**
Private Doctor/HMO 53% 17%
Hospital ED, Outpatient 18% 27%
Community Clinic (public)
5% 21%
HIV Counseling &Testing 5% 9%
* National Health Interview Survey, 2006
** Supplement to HIV/AIDS Surveillance, 2000-2003
![Page 18: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/18.jpg)
The Solutions/Results• Implement routine HIV testing in all
health care settings per the 2006 CDC Recommendations. MMWR 2006; 55 (RR14); 1-17
• Establishing early care for HIV positive patients results in better survival gains than chemotherapy (non-small cell lung cancer), adjuvant chemotherapy (breast cancer), acute myocardial infarction, and bone marrow transplant. Walensky et al. JID, 2006
![Page 19: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/19.jpg)
19
![Page 20: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/20.jpg)
Objectives of the 2006 Revised Recommendations
• Increase HIV screening in health-care / medical settings.
• Foster earlier detection of HIV infection
• Identify and counsel persons with unrecognized HIV infection and link them to services
• Further reduce perinatal HIV transmission
![Page 21: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/21.jpg)
Revised RecommendationsAdults and Adolescents
• Routine, voluntary HIV screening for all persons 13-64 in health care settings, not based on risk. (Opt-out HIV screening with the opportunity to ask questions and the option to decline testing)
• Repeat HIV testing of persons with know risk at least annually
![Page 22: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/22.jpg)
Revised RecommendationsAdults and Adolescents
• When acute retroviral infection is a possibility, use an RNA test in conjunction with an HIV antibody test
• Settings with low or unknown prevalence:– Initiate screening– If yield from screening is less than 1
per 1000, continued screening is not warranted
![Page 23: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/23.jpg)
Revised RecommendationsAdults and Adolescents
• Include HIV consent with general consent for care. A separate signed informed consent should not be required
• Prevention counseling in conjunction with HIV screening in health care settings should not be required
• Arrange access to care, prevention, and support services for patients with positive HIV test results
![Page 24: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/24.jpg)
Consent for HIV Testing
• Texas Health & Safety Code Sections 81.105 & 81.106 do not require a separate consent form for HIV.
• Client must sign general consent for medical treatment.
• Verbal consent for HIV testing must be documented and constitutes informed consent.
![Page 25: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/25.jpg)
Will this work in Texas? • Opt-out HIV testing in STD clinics 1999• Opt-out HIV testing pregnant women
1997
0
10
20
30
40
50
60
70
90 91 92 93 94 95 96 97 98 99 00 01 02 03 04 05 06 07 08 09
Year of Birth
No.
of P
erin
atal
ly In
fect
ed
![Page 26: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/26.jpg)
81.105. Informed Consent(a) Except as otherwise provided by law, a
person may not perform a test designed to identify HIV or its antigen or antibody without first obtaining the informed consent of the person to be tested.
(b)Consent need not be written if there is documentation in the medical record that the test has been explained and the consent has been obtained.
![Page 27: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/27.jpg)
Consent• 81.106. General Consent
(a) A person who has signed a general consent form for the performance of medical tests or procedures is not required to also sign or be presented with a specific consent form relating to medical tests or procedures to determine HIV infection, antibodies to HIV, or infection with any other probable causative agent of AIDS that will be performed on the person during the time in which the general consent form is in effect.
![Page 28: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/28.jpg)
§ 81.109 COUNSELING REQUIRED FOR POSITIVE TEST RESULTS
A positive test result may not be revealed to the person tested without giving them the immediate opportunity for individual, face-to-face post-test counseling about: the meaning of the test result; the possible need for additional testing; measures to prevent the transmission of HIV; the availability of appropriate health care
services, including mental health care, and appropriate social and support services in the geographic area of the person's residence
the benefits of partner notification; the availability of partner notification
programs.
![Page 29: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/29.jpg)
Criteria that Justify Routine Screening
1. Serious health disorder that can be detected before symptoms develop
2. Treatment is more beneficial when begun before symptoms develop
3. Reliable, inexpensive, acceptable screening test
4. Costs of screening are reasonable in relation to anticipated benefits
5. Treatment must be accessible
Principles and Practice of Screening for Disease -WHO Public Health Paper, 1968
![Page 30: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/30.jpg)
Benefits of Routine Testing
• Identify new HIV cases earlier• Early diagnosis and treatment leads
to:– better prognosis, – greater response to therapy, – reduced viral load, – lower transmission of HIV, – slower clinical progression, and– reduced mortality.
![Page 31: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/31.jpg)
Benefits of Routine Testing
• Prevention of new cases of HIV– Reduce the number of persons unaware
of their HIV status who knowingly transmit the virus to their partners and contacts.
• Increase the number of persons who know their HIV status– Too few persons are being tested for HIV
in Texas.– 1 in 3 HIV infected Texans are diagnosed with
AIDS within one year of their HIV diagnosis.
![Page 32: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/32.jpg)
Benefit of Early Diagnosis - Patient
• Late diagnosis has a higher risk of clinical events and death;
• More likely to have a poorer response when HAART is begun [1];
• Initiating therapy at higher CD4 counts has better prognosis [2]; &
• Cost of treating late diagnosis patients is more than 2 times higher [3].
1. Skowron G, Street J, Obee E. J Acquir Immune Defic Syndr. 2001; 28: 313-9.2. Klein D, Hurley L, Merrill D, et al. JAIDS. 2003; 32(3): 143-52.3. Krentz HB, Auld MC, Gill MJ. HIV Med. 2004; 5: 93-8.
![Page 33: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/33.jpg)
Missed Opportunities for HIV Diagnosis
A CDC report examined HIV/AIDS case reporting before the 2006 guidelines were developed & looked at healthcare visits that occurred during 1997 to 2005 in S Carolina:
– During 2001 to 2005 a total of 4,315 case of HIV infection were reported in S Carolina;
– 1,784 (42%) developed AIDS within 1 year of HIV test;– 1,302 (73%) made 7,988 previous health-care visits
(median 4 per patient) but were not tested for HIV;– 6,303 (79%) were visits to emergency departments; &– Diagnosis codes for 6,277 (79%) of prior visits would
not have prompted an HIV test.
MMWR December 1, 200633
![Page 34: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/34.jpg)
What’s the Point?
• Reduce the number of new HIV infections
• Reduce health disparities
• Increase access to and use of HIV care and treatment
![Page 35: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/35.jpg)
The ethical dilemma – To test or not to test?
• What determines the ethical standards we follow?
• What do we base our ethical standards on?
• How do these standards get applied to specific situations, specifically to routine HIV testing?
![Page 36: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/36.jpg)
5 sources of ethical standards
• Utilitarian• Rights• Fairness or justice• Common good• virtue
![Page 37: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/37.jpg)
Utilitarian Approach
• The ethical act is one that provides the most good or does the least harm, or
• Produces the greatest balance of good over harm for all.
• Deals with consequences and tries to increase the good done or reduce the harm done.
![Page 38: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/38.jpg)
Rights Approach
• The act that best protects and respects the moral rights of those affected.
• Begins with the belief that humans have a dignity based on their human nature per se or on their ability to choose freely what they do with their lives.
• The right to make one’s own choices.
![Page 39: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/39.jpg)
Fairness or Justice Approach
• All equals should be treated equally.
• Equal access to treatment and care.
![Page 40: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/40.jpg)
Common Good Approach• Life in community is a good in itself• Our actions should contribute to that life• Interlocking relationships of society are
the basis of ethical reason and that respect and compassion for all others-especially the vulnerable-are requirements for such reasoning.
• Common conditions that are important to the welfare of everyone, e.g., laws, health care, etc.
![Page 41: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/41.jpg)
Virtue Approach
• Ethical actions should be consistent with certain ideal virtues that provide the full development of our humanity.
• Dispositions and habits that enable us to act according to the highest potential of our character and on behalf of values like honesty, courage, compassion, generosity, tolerance, etc.
![Page 42: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/42.jpg)
Not everyone agrees on…
• A standard behavior• The same set of human and civil
rights• What is a ‘good’ and what is a ‘harm’
• The different approaches may not answer “What is ethical?” in the same way
![Page 43: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/43.jpg)
Making Ethical Decisions
• Need to explore the ethical aspects of a decision
• Need to weigh the considerations that should impact the choice of a course of action.
![Page 44: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/44.jpg)
HIV and AIDS
• Have had an enormous impact on health care provision
• Has forced medical community to openly address the needs of populations who have historically been marginalized in our society (gay men and IV drug users)
![Page 45: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/45.jpg)
Response to HIV/AIDS
• Federal level – rapid approval of medicines by the FDA
• State and city health departments – organize culturally sensitive, anonymous HIV counseling and testing centers
• Individual level – physicians confront their own biases to provide ongoing care for a new and possibly transmissible epidemic.
![Page 46: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/46.jpg)
AMA Opinion 2.23 – HIV Testing
• Physicians’ duties to promote patients’ welfare and to improve the public’s health are fostered by routinely testing their adult patients for HIV.
• Physicians must balance these obligations with their concurrent duties to their individual patients’ best interest by the guidelines that follow:
![Page 47: To Test or Not To Test](https://reader034.fdocuments.us/reader034/viewer/2022051001/568147e5550346895db51f00/html5/thumbnails/47.jpg)
AMA Guidelines
Support routine universal routine universal opt-out HIV screening.
Recommend/encourage patients to be screened.
Ensure HIV positive patients receive appropriate follow-up care and counseling.
Comply with applicable disease reporting laws.